Preventing and Treating Complications of Sickle Cell Disease in Pediatric Patients by Ferguson, Keandra S.
Columbus State University 
CSU ePress 
Theses and Dissertations Student Publications 
2014 
Preventing and Treating Complications of Sickle Cell Disease in 
Pediatric Patients 
Keandra S. Ferguson 
Follow this and additional works at: https://csuepress.columbusstate.edu/theses_dissertations 
 Part of the Nursing Commons 
Recommended Citation 
Ferguson, Keandra S., "Preventing and Treating Complications of Sickle Cell Disease in Pediatric Patients" 
(2014). Theses and Dissertations. 175. 
https://csuepress.columbusstate.edu/theses_dissertations/175 
This Thesis is brought to you for free and open access by the Student Publications at CSU ePress. It has been 
accepted for inclusion in Theses and Dissertations by an authorized administrator of CSU ePress. 

Preventing and Treating Complications of Sickle Cell Disease in Pediatric Patients 
by 
Keandra S. Ferguson 
A Thesis Submitted in Partial Fulfillment of 
Requirements of the CSU Honors Program 
for Honors in the degree of 
Bachelor of Science 
in 
Nursing 
College of Education and Health Professions 
Columbus State University 
Thesis Advisor Date 
Lisa O'Steen, RN, MSN, CNE 
Committee Member Date 
Stacey Meyers-Prosyniuk, RN, MSN, APRN-BC, PMHNP 
Honors Program Director Date 
Dr. Cindy Ticknor 
*a»« 
saam 
PREVENTING AND TREATING COMPLICATIONS 2 
Preventing and Treating Complications of Sickle Cell Disease in Pediatric Patients 
Sickle cell anemia, also known as sickle cell disease, affects over 90,000 people in the 
United States alone with those of African descent being at greater risk (Dobson & Byrne, 2014). 
Worldwide, it affects over 30 million people (Khoury, Musallam, Mroueh, & Abboud, 2011). It 
is usually detected during first year of life. After that, it is a lifelong disease (Hollins et al., 
2012). Patients with sickle cell disease in the United States are expected to live until they are 
approximately 48 years old (BMJ Group, 2011). It is classified as an autosomal recessive 
disorder of the blood. A child inherits abnormal hemoglobin from both their mother and father 
which causes their red blood cells to become distorted or sickled (Shiel, 2014). The hemoglobin 
that is abnormal is known as hemoglobin S or Hb S. 
Although the terms sickle cell anemia and sickle cell disease are often used 
interchangeably, sickle cell anemia is actually the most common type of sickle cell disease. 
Sickle cell anemia is the most common type of sickle disease and is caused by the homozygous 
state or Hb SS (Musumadi, Westerdale, & Appleby, 2012). Hb SS makes the red blood cell more 
"susceptible to be modulated by stress, hypoxia, and by the inflammatory response" (Odievre, 
Verger, Silva-Pinfo, & Elion, 2011, p. 533). 
Sickle cell disease can cause many problems in individuals. Some of these problems 
include anemia, pain, stroke, and severe infections (Thompson & Steinberg, 2012). These 
individuals are frequent patients in the hospital. They often seek treatment after experiencing a 
sickle cell crisis. One of the main focuses for treating sickle cell disease is hydration. This also 
helps with the prevention of sickle cell crises. However, there are many more options for treating 
sickle cell disease which depends on what the patient's presenting symptoms are. 
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In order to effectively treat and manage sickle cell disease and prevent sickle cell crisis, it 
is imperative that a nurse understands the possible complications associated with the disease. 
After analyzing which complications the patient is at risk for or are already having, the nurse can 
then properly intervene. Proper nursing interventions should be based on evidence based 
practice. It is especially important to be able to think critically when caring for pediatric clients 
as they may not be able to convey their symptoms as most adults would. Pediatric patients may 
also be more susceptible for more complications or more severe complications because their 
bodies are not fully developed. In order to prevent further complications in pediatric patients and 
lower the mortality rate, nurses must use the most effective interventions and must also intervene 
quickly. 
Pain 
Pain is one of the most common symptoms experienced by patients with sickle cell 
disease. It is the main reason sickle cell patients come to the hospital for treatment. When 
deoxygenated, the abnormal hemoglobin causes the red blood cell to become sickled or crescent 
shaped. This is due to crystallization and polymers being formed (Musumadi et al., 2012). When 
the cell becomes sickled, it leads to the occlusion of small blood vessels because the red blood 
cells are not able to easily pass through the blood vessels. The limitation of blood flow can lead 
to ischemia, or insufficient blood supply to the organs. A painful vaso-occlusive crisis occurs 
when the sickle cells become attached to endothelium and causes inflammation and tissue 
damage. Pain experienced with sickle cell disease can be either acute or chronic or a mixture of 
both. Pain may also be classified as neuropathic. 
Acute Pain 
IBM 
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The type of pain associated with the majority of hospitalizations is acute. This may also 
be referred to as an acute crisis. It often occurs after increased emotional stress, cold weather, 
asthma, extreme temperature changes, dehydration, and/or infection (Myers & Eckes, 2012). It 
may also be brought on by alcohol intoxication, pregnancy, hypoxia, acidosis, and hypovolemia 
(Maakaron & Taher, 2013). A crisis warrants for prompt medical management (Myers & Eckes, 
2012). Acute pain experienced with sickle cell disease can be compared with pain associated 
with cancer. Although there are some precipitating factors, pain is often unpredictable (Dobson 
& Byrne, 2014). The most common first sign of acute crisis presents as dactylitis, or pain and 
inflammation in the fingers and toes. Pain may be present in any part of the body especially the 
joints, abdomen, bones and soft tissue. It can last for several hours (Maakaron & Taher, 2013). In 
order to manage acute pain, nurses should encourage their patients to routinely follow up with 
their healthcare provider and, if possible, the same healthcare provider should be seen each time 
(Ballas, 2011). 
Because sickle cell disease affects the blood flow to various organs, the patient should 
also be seen by a multidisciplinary team. This is a way to make sure the patient receives proper 
assessments and is treated in the most effective way. Specialist may collaborate in order to come 
up with the best plan of care for the patient. While in the hospital, the patient may need to 
receive medication to control their pain. Intravenous medications can be challenging to give to 
sickle cell disease patients because of dehydration, decreased blood flood, multiple accesses and 
veins that are difficult to cannulate. It has been proposed to administer patient controlled 
analgesics, or PCA, subcutaneously rather than through an intravenous line (Myers & Ekes, 
2012). Although there is not much recent research, some hospitals have been noted to use 
diamorphine in subcutaneous infusions in order to manage pain in sickle cell disease. It can be 
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used as an alternate to intermittent injections as both have the same effectiveness. Subcutaneous 
infusions have been found to be better than using non-steroidal anti-inflammatory drugs, 
(NSAIDs). NSAIDs should not be used for long periods as they worsen complications of sickle 
cell disease (Okpala & Tawil, 2002). Although PCA may be better than NSAIDs, it still has 
many side effects and complications including respiratory distress and acute chest syndrome. 
Patients' respiratory statuses should be assessed frequently when being administered any type of 
opioids. 
There are pain managements that do not have any side effects reported. Guided imagery 
is being tested as a way to manage acute pain episodes in sickle cell disease patients (Dobson & 
Byrne, 2014). Guided imagery can be defined as "any of various techniques.. .used to guide 
another person or oneself in imagining sensations—especially in visualizing an image in the 
mind—to bring about a desired physical response" (National Center for Complementary and 
Alternative Medicine, 2013). Although it is typically used to reduce stress and anxiety, it can 
also be used to lower blood pressure and manage pain (American Cancer Society, 2008). This 
type of management can be very beneficial because there are no possible side effects, allergic 
reactions, or interactions with medications or foods. One downfall of guided imagery use with 
children is that the child must be able to learn how to use guided imagery. In a study performed 
on children aged six to eleven, it was found that guided imagery decreased the number of pain 
episodes while also decreasing the pain intensity. The children did not use as many pain 
medications. Many of the children did not have to use pain medications at all. If a child did use 
pain medication, they only used ibuprofen versus all of the opioids that they had prescribed to 
them. Due to the decrease in pain, the children were able to attend school more (Dobson & 
Byrne, 2014). Guided imagery should be used as the main prevention and treatment of pain 
&m 
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experienced in children with sickle cell disease. It has been proven effective in decreasing pain. 
If a child can use guided imagery, it can help to prevent further complications that are induced or 
worsened by pain medications. The child should have access to pain medication on an as needed 
basis for pain that becomes too severe or is unrelieved by guided imagery. Guided imagery is 
also cost effective because pain medication does not have to be ordered as frequently and 
complications do not have to be treated. However, patients should still routinely follow up with 
their health care providers for evaluation. If their pain becomes too severe, other pain 
management options should be explored for that patient. Bed rest is also important during a crisis 
whether or not the patient is using guide imagery and/or other pain management options 
(Thompson & Steinberg, 2012). 
Chronic Pain 
Chronic pain is characterized as three or more months of continuous pain (Ballas, 2011). 
It is often felt in the bones and joints (Maakaron & Taher, 2013). There are two main causes of 
chronic pain. One cause is from factors that can be seen such as necrosis or leg ulcers. The 
second cause is frequent, severe acute crises especially when left untreated which leads to blood 
vessel damage. Both of these result in a nagging, achy, and/or deep pain that does not go away 
(Ballas, 2011). 
In order to prevent a patient from having chronic pain or to at least prolong chronic pain 
from happening, patient should be seen and treated in a hospital for each acute crisis that they 
incur. The patient should also try to prevent acute crises from happening by staying hydrated and 
practicing stress relief exercises. Some studies have also shown that there is a correlation 
between vitamin D deficiency and chronic pain (Osunkwo et al., 2012). Vitamin D is a fat 
soluble vitamin that can be acquired from some foods and ultraviolet rays. A serum 25- 
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hydroxy vitamin D level of less than twelve nanograms per milliliter is associated with vitamin D 
deficiency. Children are recommended to have an intake of 400 to 600 IU or 10 to 15 
micrograms of vitamin D daily (Office of Dietary Supplements, 2011). People with sickle cell 
disease are more at risk to develop vitamin D deficiency (Rovner et al., 2008). Patients whose 
vitamin D levels are low and are not receiving vitamin D supplementation tend to have more 
pain days than those that receive high doses of vitamin D (Osunkwo et al., 2012). More recent 
studies have not found any correlations between vitamin D deficiency and chronic pain in sickle 
cell disease patients. However, all the patients in this particular study did not receive a high dose 
of vitamin D; they all just experienced some form of vitamin D deficiency (Jackson, Krauss, 
DeBaun, Strunk, & Arbelaez, 2012). With this being said, there is a possibility that the patients' 
pain days may have decreased if they had received a vitamin D supplementation during this 
study. Even so, high doses of vitamin D as a preventative and/or treatment for chronic pain needs 
to be further studied in order to get a conclusive result before implementation. Although 
supplementing vitamin D may not treat chronic pain experienced in those with sickle cell 
disease, nurses should still encourage their patients to have an adequate intake of vitamin D or 
get supplementation in order to avoid complications of vitamin D deficiency such as bone 
fragility, rickets, hypertension and type II diabetes (Kovacs & Stoppler, 2013). Chronic pain 
prevention and treatment also includes the ones associated with acute pain such as pain 
medications and guided imagery. Patients should follow up with their healthcare providers to 
find a regimen that works best for them. During hospital stays, patients should be monitored 
carefully especially when using opioids. Nurses need to report any signs and symptoms of 
adverse effects so that changes may be made if necessary. 
Neuropathic Pain 
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Patients may also experience neuropathic pain. Neuropathic pain can be "defined as pain 
primarily initiated by dysfunction of the peripheral or central nervous system" (Brandow, Farley, 
& Panepinto, 2014, p. 512). Neuropathic pain is "persistent pain resulting from damage to the 
peripheral or central nervous system (CNS) or abnormal communication within the nervous 
system" (Wang, Wilkie, & Molokie, 2010, p. 403). Symptoms associated with neuropathic pain 
include tingling, numbness, and burning and shooting pain (Cassoobhoy, 2013). It may be 
caused by tissue damage as result of vaso-occlusion. It can also be due to the treatment of 
chronic pain from the activation of neuroglia (Ballas, 2011). Neuroglia are "[njonneuronal 
cellular elements of the central and peripheral nervous system; thought to have important 
metabolic functions" (Farlex, 2012). 
In order to prevent patients from experiencing neuropathic pain, nurses should be 
cautious when administering medications for pain. Nurses should also make sure their patients 
stay hydrated as a way to prevent tissue damage which can lead to neuropathic pain. Whenever a 
patient experiences an acute crisis, they should be treated quickly in order to prevent irreversible 
tissue damage (Ballas, Gupta, & Adams-Graves, 2012). Treating neuropathic pain with pain 
medications should be avoided as they can worsen it. Possible treatment options for neuropathic 
pain include electrical stimulation, physical therapy, acupuncture, and relaxation therapy 
(Cassoobhoy, 2013). Nurses should communicate with both the patient and the healthcare 
provider in order to determine the best treatment for the patient. If the patient has to take pain 
medication for acute or chronic pain, the nurse should educate the patient on signs and symptoms 
of worsening neuropathic pain. The patient should be instructed to notify their healthcare 
provider if they start experiencing worsening neuropathic in order to avoid serious disabilities 
(Cassoobhoy, 2013). 
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Infection 
Another possible complication associated with sickle cell disease is infection. Patients 
with sickle cell disease are at greater risk for acquiring infections due to spleen damage. 
Pneumonia is one of the main causes of death among infants and young children with sickle cell 
disease (Centers for Disease Control and Prevention, 2014). In order to prevent infection, a child 
will begin taking penicillin twice daily before they are two months old. This prophylactic dosing 
will continue until the child is at least five years old (Adis Medical Writers, 2013). Vaccines 
should also be given and kept up to date. This especially includes those for influenza, 
meningococcal disease, pneumonia, and any other that are recommended by the health care 
provider. Proper hand washing done by the patient, family, and nurse can also prevent the patient 
from getting an infection. The nurse should also provide education on food safety to avoid 
salmonella. This includes washing fruits and vegetables, thoroughly cooking meat, only eating 
pasteurized dairy products, and not eating raw eggs or products with raw eggs. Reptiles may also 
have salmonella so patients should be advised to stay away from turtles, snakes, and lizards. 
Patients and parents should be encouraged to contact or visit their health care provider if they 
have any signs of infection (Centers for Disease Control and Prevention, 2014). Children 
presenting with a fever should be seen by their health care provider as they may have an 
infection or are at a greater risk for acquiring an infection (Bansil, Kim, Tieu, & Barcega, 2013). 
Infections need to be treated as early as possible with antibiotics in order to prevent further 
complications (Centers for Disease and Control and Prevention, 2014). 
Acute Chest Syndrome 
Another complication of sickle cell disease is acute chest syndrome. Acute chest 
syndrome is a group of symptoms associated with sickle cell disease. It is characterized by 
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severe pain, pulmonary infiltrates, chest pain, leukocytosis, tachycardia, and tachypnea (Myers & 
Eckes, 2012). Pediatric patients with acute chest syndrome may also experience fever, cough, 
and wheezing. It is another reason why people with sickle cell disease are hospitalized and also 
the leading cause of death among patients with sickle cell disease (Khoury et al., 2011). Pediatric 
patients are more likely to get acute chest syndrome especially between the ages of two and four. 
Patients are also at risk three days following surgery (Nasser & Hassan, 2011). Acute chest 
syndrome happens during acute crisis when the bone marrow is involved which causes fat 
embolisms inside of the lungs (Myers & Eckes, 2012). Fat embolisms are the number one cause 
of acute chest syndrome in adults (Nasser & Hassan, 2011). After a bone marrow infarction, 
bone marrow contents can create pulmonary emboli (Khoury et al., 2011). If a sickle cell patient 
is experiencing bone pain, they likely have a bone marrow infarction and should be monitored 
for acute chest syndrome (Maakaron & Taher, 2013). Acute chest syndrome may also be a result 
of infections such as those caused by Mycoplasma pneumoniae and Streptococcus pneumoniae. 
Infection is the number one cause of acute chest syndrome in children (Nasser & Hassan, 2011). 
Children should be monitored for signs and symptoms of infections. Nurses should take 
precautions in order to decrease the amount of germs spread to prevent the child from acquiring 
an infection. If the patient is taking hydroxyurea, they should have their white blood cell count 
monitored as it may lowered which puts them at risk for infection (Centers for Disease Control 
and Prevention, 2014). Antibiotics should be used to treat the infection (Thompson & Steinberg, 
2012). 
Morphine use in the treatment for acute crisis has been identified as a risk for developing 
acute chest syndrome (Birken et al., 2013). Having too much of an opioid analgesic can cause 
acute chest syndrome due to it depressing the respiratory system (Ballas, Kesen, et al., 2012). 
WBBBHBar 
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Taking this into account, it is imperative that nurses monitor their patients who are receiving 
morphine or any opioid analgesic. Routine respiratory assessments should be done in order to 
prevent acute chest syndrome. If possible, opioid analgesics should only be used when needed. 
They should not be used in mass amounts or as a preventative pain management as they can 
precipitate acute chest syndrome. Other treatments, such as guided imagery, should be explored 
for pain as to avoid further respiratory complications. If it is absolutely necessary that a patient 
receives an opioid analgesic such as morphine, it should be used carefully. If the patient's 
respiratory rate falls below the normal range, the opioid analgesic should be discontinued. 
Pediatric patients should have respirations between twelve and sixty depending on their age 
(New York State Health Department, n.d.). Opioid antagonist such as Narcan should be kept on 
hand in order to reverse any possible adverse effects. Patients receiving opioids or patients that 
recently had opioids prior to acquiring acute chest syndrome should be encouraged to do deep 
breathing (Thompson & Steinberg, 2012). 
For preventive measures, studies have proven that "specified patient monitoring with 
criteria for the initiation of supplemental oxygen; scheduled incentive spirometry; patient 
ambulation after the first 24 hours; opioid type and dosing schedule, maintenance and 
exacerbation asthma orders, and opioid titration and weaning guidelines" will decrease the rate 
of patients with acute chest syndrome when being managed for pain (Reagan, DeBaun, & Frei- 
Jones, 2011, p. 263). One of the main focuses for treating acute chest syndrome is maintaining 
ventilation by incentive spirometer for mild cases or mechanical ventilation for severe cases 
(Ballas, Kesen, et al., 2012). The use of the incentive spirometer is especially important for 
patients who are on bed rest or who had a recent surgery (Centers for Disease Control and 
Prevention, 2014). Pain management, oxygen therapy, and blood transfusions may also be 
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indicated for treatment (Thompson & Steinberg, 2012). Corticosteroids, however, should be 
avoided as they may prolong hospital stay and increase the risk for readmission. Bronchodilators 
may be used for patients that are wheezing or also have asthma (Khoury et al., 2011). The nurse 
needs to keep track of the patient's intake and output due to the possibility of fluids building up 
in the lungs (Thompson & Steinberg, 2012). 
Renal Complications 
Children with sickle cell disease may also suffer from renal complications due to 
sickling. One common renal complication is hyposthenuria (Musumadi et al., 2012). 
Hyposthenuria is the "[ejxcretion of urine of low specific gravity due to an inability of the 
tubules of the kidneys to produce concentrated urine" (Dictionary.com, 2002). This can cause the 
patient to excrete large amounts of urine which leads to dehydration. Dehydration may cause the 
patient to go into a vaso-occlusive crisis (Musumadi et al., 2012). It is important for the nurse to 
assess their patient of signs and symptoms of dehydration. The nurse should also educate their 
patient on proper hydration. Patients may also experience glomerular hyperfiltration during their 
adolescent years (Adis Medical Writers, 2013). As a nurse, one needs to monitor their patient's 
kidney function. Glomerular hyperfiltration may result in renal failure later in life (Paula, 
Nascimento, Sousa, Bastos, & Barbosa, 2013). Non-steroidal anti-inflammatory may prevent 
glomerular hyperfiltration; however, it should not be used because it can cause adverse effects in 
relation to the kidneys. Patients with sickle cell disease may also have hematuria and 
proteinuria, which has the possibility of leading to renal failure. The patient should have 
urinalyses done to determine if there is any blood or protein in the urine. If a patient presents 
with hematuria, the nurse has to make sure the patient stays on bed rest and maintains adequate 
hydration. In order to decrease proteinuria, the patient will be prescribed angiotensin-converting 
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enzyme inhibitors or angiotensin receptor blockers. Both have been proven to reduce proteinuria 
and should be used even if the patient does not have hypertension (Lerma & Batuman, 2012). 
However, if the patient is receiving angiotensin-converting enzyme inhibitors, serum potassium 
level should be monitored because they are at risk for developing hyperkalemia (Becker, 2011). 
The administration of supplemental vitamin E may also be used due to its antioxidant effects. If 
the patient does progress to end stage renal failure, a kidney transplant may be considered. 
Transplant recipients should have their fluid intake and output strictly monitored as they are 
more at risk to have acute sickle cell crises (Lerma & Batuman, 2012). Nurses need to make sure 
their patients receiving transplants maintain adequate hydration in order to avoid these crises 
especially after episodes of vomiting and/or diarrhea. 
Complications of the Eyes 
Sickle cell patients also have the possibility of acquiring vision problems. Cells that are 
sickled can become lodged in the blood vessels of the retina (Thompson & Steinberg, 2012). 
This can lead to partial or complete blindness. In severe cases, retinal hemorrhaging can occur 
and the retina can become detached which typically leads to permanent blindness (Shiel, 2014). 
Retinal detachment can happen unexpectedly. Early detection is key. Sickle cell patients should 
have routine visits with an ophthalmologist (Thompson & Steinberg, 2012). Laser treatments are 
an option if it is detected early (Shiel, 2014). 
Cerebrovascular System 
Cells that are sickled may obstruct the flow of blood to the brain. This can potentially 
lead to the patient experiencing a stroke (Centers of Disease Control and Prevention, 2014). 
Because strokes can be fatal, it is important that nurses know the signs and symptoms associated 
with stroke and also teach parents. Signs and symptoms include weakness or numbness in the 
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extremities, sudden changes in speech, seizures, and loss of consciousness. If a child exhibits any 
of these symptoms, interventions must be done immediately in order to prevent death (Mayo 
Clinic, 2011). Even if death is avoidable, the child can still have long term effects such as 
learning problems, disability, paralysis, and brain damage (National Heart, Lung, and Blood 
Institute, 2012). Children with sickle cell disease should be examined in order to be determined 
if they are at risk for stroke. This can be done using a transcranial Doppler ultrasound (Centers 
for Disease Control and Prevention, 2014). Abnormal mean velocity flow may be present in 
those at risk for stroke (Lakhkar, Lakhkar, & Vaswani 2012). 
One possible way to prevent stroke is through blood transfusions. Blood transfusions 
should be done on a monthly basis for patients who are at risk for or who have already had a 
stroke (Adis Medical Writers, 2013). They have been proven to prevent recurrent strokes in 
patients that have already had a stroke. However, the patient would need blood transfusions for 
the rest of their life due to the high probability of having a stroke after cessation (Verduzco & 
Nathan, 2009). Continuing blood transfusions puts the patient at risk for iron overload which can 
be life threatening (Centers for Disease Control and Prevention, 2014). It can cause liver 
damage, heart damage, lung damage, and damage to the endocrine organs. This may lead to 
cirrhosis, heart failure, pulmonary hypertension, diabetes, and delayed puberty (Mir & Logue, 
2014). Even so, the benefits outweigh the risks until better options are made available. If a 
patient is receiving blood transfusions, iron levels should be monitored. The patient should also 
receive iron chelation therapy in order to prevent complications of iron overload (Centers for 
Disease Control and Prevention, 2014). 
Erythrocytapheresis has been viewed as one alternative option to blood transfusions and 
it appears to have fewer risks associated with it. Erythrocytapheresis is "the withdrawal of blood, 
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separation and retention of red blood cells, and retransfusion of the remainder into the donor" 
(Saunders, 2007). It is safer than blood transfusions and it can also be used to prevent and treat 
other complications caused by sickle cell disease (Ullrich et al, 2008). Erythrocytapheresis has 
been noted to be effective for the treatment of acute chest syndrome as well as maintaining 
respiratory status (Velasquez, Mariscalco, Goldstein, & Airewele, 2009). 
Curing Sickle Cell 
Although there are many different options for the prevention and treatment of the 
complications associated with sickle cell disease, there are no methods to prevent acquiring 
sickle cell disease. There are a few curative procedures. One of the main methods to cure sickle 
cell disease is stem cell transplant (Thompson & Steinberg, 2012). Stem cells are extracted from 
peripheral blood, bone marrow or cord blood. Complications of stem cell transplantation include 
anemia, seizures, electrolyte imbalances, infertility, and infection. Due to the various life 
threatening complications, stem cell transplantation is only used for certain cases. In order to 
prevent these complications, the patient should be advised to have a sibling or parent to be their 
donor if possible. The patient should also undergo a myeloablative or nonmyeloablative 
preparative regimen before having the stem cell transplant (Thompson, Ceja, & Yang, 2012). 
Patients should be monitored for signs and symptoms of infection. Precautions should be taken 
in order to prevent infection including good hand washing, providing patient with a private room, 
and wearing appropriate personal protective equipment. Labs should also be drawn in order to 
monitor electrolytes. 
Conclusion 
Sickle cell disease is a disorder that affects millions worldwide. Children are often 
admitted to the hospital repeatedly due to complications. Even though sickle cell disease cannot 
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be prevented, there are ways to prevent and treat the complications associated with it. Pain can 
be severe and affect a person's daily life. Patients taking morphine or other pain medications 
have been known to stay at the same pain level and have recurrent pain episodes. Guided 
imagery should be used as the first line for prevention and treatment of pain episodes. Acute 
chest syndrome can be caused by infection and some of the treatments for pain. These patients 
should be encouraged to use incentive spirometers and take antibiotics. All sickle cell patients 
should take precautions to avoid acquiring infection in order to prevent vaso-occlusive crises and 
acute chest syndrome. Patients should also have their renal functioning assessed frequently. They 
should also follow up with an ophthalmologist regularly. Transcranial Doppler ultrasounds 
should also be performed in order to determine patients at risk for stroke. Patients having severe 
complications of sickle cell disease may be considered for stem cell transplantation. It is 
imperative to prevent all these complications in order to lengthen the life expectancy for patients 
and also improve their quality of life. 
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